Molecular Diagnostics in Infectious Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
Polymerase Chain Reaction (PCR) Segment Leading the Market Growth
• North America Emerging as Dominant Region
The global molecular diagnostics in infectious disease testing market, valued at US$ 57 billion in 2024, is projected to reach an estimated US$ 83 billion by 2031.
Market Overview
Molecular diagnostics in infectious disease testing involves the detection of genetic materials and proteins associated with specific health conditions and infectious agents in body fluids. Hospitals, academic institutions, laboratories, and others widely use this technique. The market is driven by an increasing number of infectious diseases, technological advancements in diagnostic technologies, and government support for disease diagnosis and prevention. However, high instrument costs and a shortage of skilled healthcare professionals present challenges.
Factors Driving Market Growth
• High Incidence of Infectious Diseases Worldwide: The prevalence of infectious diseases like influenza, COVID-19, HIV, hospital-acquired infections (HAIs), and hepatitis, coupled with the need for point-of-care diagnostics, is expected to drive market growth.
• Expanding Geriatric Population: The global geriatric population is expanding, making them more vulnerable to infectious diseases like COVID-19. Regular testing to prevent severe illnesses presents growth opportunities, especially in countries with aging populations.
• Polymerase Chain Reaction (PCR) Segment Leading: The PCR segment is expected to dominate the market, owing to its traditional use in infectious disease diagnosis and advancements in technology, including high-throughput PCR for coronavirus detection.
Regional Dominance
North America is set to lead the global molecular diagnostics in infectious disease testing market, driven by regulatory support, increased investment in diagnostics, growing demand for molecular testing, and the early diagnosis of infections in patients with underlying medical conditions. The prevalence of drug-resistant infections further contributes to the region's market growth.
Key Market Players
Major companies in the global molecular diagnostics in infectious disease testing market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., GenMark Diagnostics, Inc., Qiagen N.V., Genomix Biotech, and bioTheranostics.
Molecular Diagnostics in Infectious Disease Testing Industry Research Segmentation
By Product:
• Instruments and Analyzers
• Assays and Reagents
• Services and Software
By Application:
• Hepatitis B
• Hepatitis C
• AIDS
• Tuberculosis
• Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Hospital-Acquired Infections
• Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
• Human Papillomavirus (HPV) Infection
• Others
By Technique:
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Microarrays
• Next-Generation Sequencing (NGS)
• Hybridization
• Others
By End User:
• Hospitals
• Private Labs
• Clinics
• Academic Institutes
• Laboratories
• Others
By Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.
- 1. Executive Summary
- 1.1. Global Gene Expression Analysis Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2023
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Global Gene Expression Analysis Market Outlook, 2018 – 2031
- 3.1. Global Gene Expression Analysis Market Outlook, by Type of Product, Value (US$ Bn), 2018 – 2031
- 3.1.1. Key Highlights
- 3.1.1.1. Kits & Reagents
- 3.1.1.2. DNA Clips
- 3.1.1.3. Others
- 3.2. Global Gene Expression Analysis Market Outlook, by Capacity, Value (US$ Bn), 2018 – 2031
- 3.2.1. Key Highlights
- 3.2.1.1. Low – to Mid-Plex
- 3.2.1.2. High-Plex
- 3.3. Global Gene Expression Analysis Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 3.3.1. Key Highlights
- 3.3.1.1. Drug Discovery & Development
- 3.3.1.2. Clinical Diagnostics
- 3.3.1.3. Biotechnology & Microbiology
- 3.3.1.4. Others
- 3.4. Global Gene Expression Analysis Market Outlook, by Technology, Value (US$ Bn), 2018 – 2031
- 3.4.1. Key Highlights
- 3.4.1.1. Northern Blotting
- 3.4.1.2. DNA Microarrays
- 3.4.1.3. PCR techniques
- 3.4.1.4. RNA-Seq
- 3.4.1.5. Western Blotting
- 3.4.1.6. 2-D Gel Electrophoresis
- 3.4.1.7. Immunoassays
- 3.4.1.8. Mass Spectrometry
- 3.4.1.9. ChIP (Chromatin Immunoprecipitation)
- 3.4.1.10. Others
- 3.5. Global Gene Expression Analysis Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
- 3.5.1. Key Highlights
- 3.5.1.1. North America
- 3.5.1.2. Europe
- 3.5.1.3. Asia Pacific
- 3.5.1.4. Latin America
- 3.5.1.5. Middle East & Africa
- 4. North America Gene Expression Analysis Market Outlook, 2018 – 2031
- 4.1. North America Gene Expression Analysis Market Outlook, by Type of Product, Value (US$ Bn), 2018 – 2031
- 4.1.1. Key Highlights
- 4.1.1.1. Kits & Reagents
- 4.1.1.2. DNA Clips
- 4.1.1.3. Others
- 4.2. North America Gene Expression Analysis Market Outlook, by Capacity, Value (US$ Bn), 2018 – 2031
- 4.2.1. Key Highlights
- 4.2.1.1. Low – to Mid-Plex
- 4.2.1.2. High-Plex
- 4.3. North America Gene Expression Analysis Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 4.3.1. Key Highlights
- 4.3.1.1. Drug Discovery & Development
- 4.3.1.2. Clinical Diagnostics
- 4.3.1.3. Biotechnology & Microbiology
- 4.3.1.4. Others
- 4.4. North America Gene Expression Analysis Market Outlook, by Technology, Value (US$ Bn), 2018 – 2031
- 4.4.1. Key Highlights
- 4.4.1.1. Northern Blotting
- 4.4.1.2. DNA Microarrays
- 4.4.1.3. PCR techniques
- 4.4.1.4. RNA-Seq
- 4.4.1.5. Western Blotting
- 4.4.1.6. 2-D Gel Electrophoresis
- 4.4.1.7. Immunoassays
- 4.4.1.8. Mass Spectrometry
- 4.4.1.9. ChIP (Chromatin Immunoprecipitation)
- 4.4.1.10. Others
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
- 4.5. North America Gene Expression Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 4.5.1. Key Highlights
- 4.5.1.1. U.S. Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 4.5.1.2. U.S. Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 4.5.1.3. U.S. Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 4.5.1.4. U.S. Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 4.5.1.5. Canada Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 4.5.1.6. Canada Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 4.5.1.7. Canada Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 4.5.1.8. Canada Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis
- 5. Europe Gene Expression Analysis Market Outlook, 2018 – 2031
- 5.1. Europe Gene Expression Analysis Market Outlook, by Type of Product, Value (US$ Bn), 2018 – 2031
- 5.1.1. Key Highlights
- 5.1.1.1. Kits & Reagents
- 5.1.1.2. DNA Clips
- 5.1.1.3. Others
- 5.2. Europe Gene Expression Analysis Market Outlook, by Capacity, Value (US$ Bn), 2018 – 2031
- 5.2.1. Key Highlights
- 5.2.1.1. Low – to Mid-Plex
- 5.2.1.2. High-Plex
- 5.3. Europe Gene Expression Analysis Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 5.3.1. Key Highlights
- 5.3.1.1. Drug Discovery & Development
- 5.3.1.2. Clinical Diagnostics
- 5.3.1.3. Biotechnology & Microbiology
- 5.3.1.4. Others
- 5.4. Europe Gene Expression Analysis Market Outlook, by Technology, Value (US$ Bn), 2018 – 2031
- 5.4.1. Key Highlights
- 5.4.1.1. Northern Blotting
- 5.4.1.2. DNA Microarrays
- 5.4.1.3. PCR techniques
- 5.4.1.4. RNA-Seq
- 5.4.1.5. Western Blotting
- 5.4.1.6. 2-D Gel Electrophoresis
- 5.4.1.7. Immunoassays
- 5.4.1.8. Mass Spectrometry
- 5.4.1.9. ChIP (Chromatin Immunoprecipitation)
- 5.4.1.10. Others
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
- 5.5. Europe Gene Expression Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 5.5.1. Key Highlights
- 5.5.1.1. Germany Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 5.5.1.2. Germany Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 5.5.1.3. Germany Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 5.5.1.4. Germany Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 5.5.1.5. U.K. Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 5.5.1.6. U.K. Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 5.5.1.7. U.K. Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 5.5.1.8. U.K. Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 5.5.1.9. France Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 5.5.1.10. France Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 5.5.1.11. France Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 5.5.1.12. France Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 5.5.1.13. Italy Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 5.5.1.14. Italy Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 5.5.1.15. Italy Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 5.5.1.16. Italy Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 5.5.1.17. Turkey Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 5.5.1.18. Turkey Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 5.5.1.19. Turkey Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 5.5.1.20. Turkey Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 5.5.1.21. Russia Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 5.5.1.22. Russia Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 5.5.1.23. Russia Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 5.5.1.24. Russia Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 5.5.1.25. Rest of Europe Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 5.5.1.26. Rest of Europe Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 5.5.1.27. Rest of Europe Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 5.5.1.28. Rest of Europe Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis
- 6. Asia Pacific Gene Expression Analysis Market Outlook, 2018 – 2031
- 6.1. Asia Pacific Gene Expression Analysis Market Outlook, by Type of Product, Value (US$ Bn), 2018 – 2031
- 6.1.1. Key Highlights
- 6.1.1.1. Kits & Reagents
- 6.1.1.2. DNA Clips
- 6.1.1.3. Others
- 6.2. Asia Pacific Gene Expression Analysis Market Outlook, by Capacity, Value (US$ Bn), 2018 – 2031
- 6.2.1. Key Highlights
- 6.2.1.1. Low – to Mid-Plex
- 6.2.1.2. High-Plex
- 6.3. Asia Pacific Gene Expression Analysis Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 6.3.1. Key Highlights
- 6.3.1.1. Drug Discovery & Development
- 6.3.1.2. Clinical Diagnostics
- 6.3.1.3. Biotechnology & Microbiology
- 6.3.1.4. Others
- 6.4. Asia Pacific Gene Expression Analysis Market Outlook, by Technology, Value (US$ Bn), 2018 – 2031
- 6.4.1. Key Highlights
- 6.4.1.1. Northern Blotting
- 6.4.1.2. DNA Microarrays
- 6.4.1.3. PCR techniques
- 6.4.1.4. RNA-Seq
- 6.4.1.5. Western Blotting
- 6.4.1.6. 2-D Gel Electrophoresis
- 6.4.1.7. Immunoassays
- 6.4.1.8. Mass Spectrometry
- 6.4.1.9. ChIP (Chromatin Immunoprecipitation)
- 6.4.1.10. Others
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
- 6.5. Asia Pacific Gene Expression Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 6.5.1. Key Highlights
- 6.5.1.1. China Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 6.5.1.2. China Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 6.5.1.3. China Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 6.5.1.4. China Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 6.5.1.5. Japan Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 6.5.1.6. Japan Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 6.5.1.7. Japan Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 6.5.1.8. Japan Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 6.5.1.9. South Korea Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 6.5.1.10. South Korea Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 6.5.1.11. South Korea Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 6.5.1.12. South Korea Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 6.5.1.13. India Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 6.5.1.14. India Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 6.5.1.15. India Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 6.5.1.16. India Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 6.5.1.17. Southeast Asia Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 6.5.1.18. Southeast Asia Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 6.5.1.19. Southeast Asia Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 6.5.1.20. Southeast Asia Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 6.5.1.21. Rest of Asia Pacific Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 6.5.1.22. Rest of Asia Pacific Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 6.5.1.23. Rest of Asia Pacific Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 6.5.1.24. Rest of Asia Pacific Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis
- 7. Latin America Gene Expression Analysis Market Outlook, 2018 – 2031
- 7.1. Latin America Gene Expression Analysis Market Outlook, by Type of Product, Value (US$ Bn), 2018 – 2031
- 7.1.1. Key Highlights
- 7.1.1.1. Kits & Reagents
- 7.1.1.2. DNA Clips
- 7.1.1.3. Others
- 7.2. Latin America Gene Expression Analysis Market Outlook, by Capacity, Value (US$ Bn), 2018 – 2031
- 7.2.1. Key Highlights
- 7.2.1.1. Low – to Mid-Plex
- 7.2.1.2. High-Plex
- 7.3. Latin America Gene Expression Analysis Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 7.3.1. Key Highlights
- 7.3.1.1. Drug Discovery & Development
- 7.3.1.2. Clinical Diagnostics
- 7.3.1.3. Biotechnology & Microbiology
- 7.3.1.4. Others
- 7.4. Latin America Gene Expression Analysis Market Outlook, by Technology, Value (US$ Bn), 2018 – 2031
- 7.4.1. Key Highlights
- 7.4.1.1. Northern Blotting
- 7.4.1.2. DNA Microarrays
- 7.4.1.3. PCR techniques
- 7.4.1.4. RNA-Seq
- 7.4.1.5. Western Blotting
- 7.4.1.6. 2-D Gel Electrophoresis
- 7.4.1.7. Immunoassays
- 7.4.1.8. Mass Spectrometry
- 7.4.1.9. ChIP (Chromatin Immunoprecipitation)
- 7.4.1.10. Others
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
- 7.5. Latin America Gene Expression Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 7.5.1. Key Highlights
- 7.5.1.1. Brazil Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 7.5.1.2. Brazil Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 7.5.1.3. Brazil Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 7.5.1.4. Brazil Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 7.5.1.5. Mexico Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 7.5.1.6. Mexico Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 7.5.1.7. Mexico Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 7.5.1.8. Mexico Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 7.5.1.9. Argentina Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 7.5.1.10. Argentina Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 7.5.1.11. Argentina Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 7.5.1.12. Argentina Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 7.5.1.13. Rest of Latin America Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 7.5.1.14. Rest of Latin America Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 7.5.1.15. Rest of Latin America Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 7.5.1.16. Rest of Latin America Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis
- 8. Middle East & Africa Gene Expression Analysis Market Outlook, 2018 – 2031
- 8.1. Middle East & Africa Gene Expression Analysis Market Outlook, by Type of Product, Value (US$ Bn), 2018 – 2031
- 8.1.1. Key Highlights
- 8.1.1.1. Kits & Reagents
- 8.1.1.2. DNA Clips
- 8.1.1.3. Others
- 8.2. Middle East & Africa Gene Expression Analysis Market Outlook, by Capacity, Value (US$ Bn), 2018 – 2031
- 8.2.1. Key Highlights
- 8.2.1.1. Low – to Mid-Plex
- 8.2.1.2. High-Plex
- 8.3. Middle East & Africa Gene Expression Analysis Market Outlook, by Application, Value (US$ Bn), 2018 – 2031
- 8.3.1. Key Highlights
- 8.3.1.1. Drug Discovery & Development
- 8.3.1.2. Clinical Diagnostics
- 8.3.1.3. Biotechnology & Microbiology
- 8.3.1.4. Others
- 8.4. Middle East & Africa Gene Expression Analysis Market Outlook, by Technology, Value (US$ Bn), 2018 – 2031
- 8.4.1. Key Highlights
- 8.4.1.1. Northern Blotting
- 8.4.1.2. DNA Microarrays
- 8.4.1.3. PCR techniques
- 8.4.1.4. RNA-Seq
- 8.4.1.5. Western Blotting
- 8.4.1.6. 2-D Gel Electrophoresis
- 8.4.1.7. Immunoassays
- 8.4.1.8. Mass Spectrometry
- 8.4.1.9. ChIP (Chromatin Immunoprecipitation)
- 8.4.1.10. Others
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
- 8.5. Middle East & Africa Gene Expression Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 8.5.1. Key Highlights
- 8.5.1.1. GCC Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 8.5.1.2. GCC Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 8.5.1.3. GCC Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 8.5.1.4. GCC Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 8.5.1.5. South Africa Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 8.5.1.6. South Africa Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 8.5.1.7. South Africa Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 8.5.1.8. South Africa Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 8.5.1.9. Egypt Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 8.5.1.10. Egypt Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 8.5.1.11. Egypt Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 8.5.1.12. Egypt Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 8.5.1.13. Nigeria Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 8.5.1.14. Nigeria Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 8.5.1.15. Nigeria Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 8.5.1.16. Nigeria Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 8.5.1.17. Rest of Middle East & Africa Gene Expression Analysis Market by Type of Product, Value (US$ Bn), 2018 – 2031
- 8.5.1.18. Rest of Middle East & Africa Gene Expression Analysis Market by Capacity, Value (US$ Bn), 2018 – 2031
- 8.5.1.19. Rest of Middle East & Africa Gene Expression Analysis Market by Application, Value (US$ Bn), 2018 – 2031
- 8.5.1.20. Rest of Middle East & Africa Gene Expression Analysis Market by Technology, Value (US$ Bn), 2018 – 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis
- 9. Competitive Landscape
- 9.1. Type of Product vs Application Heatmap
- 9.2. Company Market Share Analysis, 2023
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Agilent Technologies, Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Development
- 9.4.2. Bio-Rad Laboratories, Inc.
- 9.4.2.1. Company Overview
- 9.4.2.2. Product Portfolio
- 9.4.2.3. Financial Overview
- 9.4.2.4. Business Strategies and Development
- 9.4.3. General Electric Company
- 9.4.3.1. Company Overview
- 9.4.3.2. Product Portfolio
- 9.4.3.3. Financial Overview
- 9.4.3.4. Business Strategies and Development
- 9.4.4. Illumina, Inc.
- 9.4.4.1. Company Overview
- 9.4.4.2. Product Portfolio
- 9.4.4.3. Financial Overview
- 9.4.4.4. Business Strategies and Development
- 9.4.5. Luminex Corporation
- 9.4.5.1. Company Overview
- 9.4.5.2. Product Portfolio
- 9.4.5.3. Financial Overview
- 9.4.5.4. Business Strategies and Development
- 9.4.6. Oxford Gene Technology IP
- 9.4.6.1. Company Overview
- 9.4.6.2. Product Portfolio
- 9.4.6.3. Financial Overview
- 9.4.6.4. Business Strategies and Development
- 9.4.7. PerkinElmer, Inc
- 9.4.7.1. Company Overview
- 9.4.7.2. Product Portfolio
- 9.4.7.3. Financial Overview
- 9.4.7.4. Business Strategies and Development
- 9.4.8. QIAGEN NV
- 9.4.8.1. Company Overview
- 9.4.8.2. Product Portfolio
- 9.4.8.3. Financial Overview
- 9.4.8.4. Business Strategies and Development
- 9.4.9. Roche Holding AG
- 9.4.9.1. Company Overview
- 9.4.9.2. Product Portfolio
- 9.4.9.3. Financial Overview
- 9.4.9.4. Business Strategies and Development
- 9.4.10. Thermo Fisher Scientific, Inc.
- 9.4.10.1. Company Overview
- 9.4.10.2. Product Portfolio
- 9.4.10.3. Financial Overview
- 9.4.10.4. Business Strategies and Development
- 10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook